OSI-7904L Uses, Dosage, Side Effects and more
OSI-7904L is a liposome encapsulated thymidylate synthase inhibitor, which is indicated for use in advanced gastric and/or gastroesophageal adenocarcinoma (A-G/GEJA). Current treatments also inhibit thymidylate synthase but the innovative lipid coating of OSI-7904L allows for more enduring results with administration of the TS inhibitor.
| Attribute | Details |
|---|---|
| Trade Name | OSI-7904L |
| Generic | OSI-7904L |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in gastric cancer.
How OSI-7904L works
Inhibits thymidylate synthase.
Toxicity
Acceptable clinical safety profile
